GLP-1T (60mg)

Manufactured in the USA by a Licensed Pharmaceutical Facility
Veteran Operated Company

GLP1-T is a synthetic dual-pathway peptide widely examined in metabolic and endocrine research models for its interaction with glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor systems. Researchers study GLP1-T for its role in appetite-signaling pathways, nutrient-response modeling, and multi-receptor hormonal coordination within controlled laboratory environments.

Due to its dual agonist profile, GLP1-T is frequently utilized in advanced research exploring synergistic signaling mechanisms related to energy balance, metabolic efficiency, and endocrine communication networks. Its extended activity profile supports longer observation windows in experimental designs focused on metabolic regulation and peptide-receptor dynamics.

Produced in a licensed U.S. pharmaceutical manufacturing facility and independently verified at ≥99% purity, Nova9 GLP1-T is engineered for consistency, stability, and reproducibility in research applications. Supplied as a lyophilized peptide, it is optimized for structural integrity during controlled laboratory handling and storage.

Made in the USA by a Licensed Pharmaceutical Facility
Veteran Operated Company

For Research Use Only. Not for human consumption, not for veterinary use, and not for diagnostic or therapeutic purposes. All purchasers certify these materials will be used exclusively in controlled laboratory research settings.